Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Kenvue Inc.

RBC Capital analyst Nik Modi maintained a Hold rating on Kenvue, Inc. yesterday and set a price target of $21.00. Modi covers the Consumer Defensiv...

Market Cap	$30.34B	P/E Ratio	15.85
52W High	$25.17	52W Low	$14.02
Div Yield	83.0%	Payout Ratio	449.4%
EPS Growth 3Y	-40.0%	52W Position	30.6%
Overall Score	59	Value Score	100
Quality Score	50	Technical Score	27

EPS Current Est	$1.1	EPS Next Est	$1.16
EPS Growth Est	+5.5%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	KVUE	$17.43	0.00%	31.03M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	KVUE	$17.43	0%	31.03M
3
4
5
6

KVUE

KVUE

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Kenvue Inc. Data in Excel

Get Kenvue Inc. Data in Excel